Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...

Researchers have created liver tissue that grows its own blood vessels, improving research into hemophilia and liver damage.

NVO is expanding into rare blood disorders like hemophilia to ease reliance on GLP-1 drugs Ozempic and Wegovy.

CSL Behring Germany today announced that the first haemophilia B patient in Germany was treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at the Hemophilia Treatment Center at ...

US President Donald Trump’s plan to drop a 200 per cent tariff bomb on Australian pharmaceuticals is set to “screw over” the ...

Hemlibra safely reduces bleeding episodes in people with hemophilia A without inhibitors, per a review study that confirmed ...

Anderson Cooper has one foot out the door at CNN, according to sources who tell the National Enquirer that the newsman’s ...

Because the truth is that not everything is as it seems. The people who face these invisible battles of chronic illness are the courageous ones. They get through each day, hoping for few or no health ...

DexCom has significant room to grow in its core market, despite disappointing results last year. One of Warren Buffett's ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...